📰 Cluster Headache News
Page 2 - Cluster Headache News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cluster Headache. Real-time updates on events, politics, business and more.
September 8, 2023
Fall is here. That means cold and flu season. But, it also means the start of RSV (respiratory syncytial virus) season. RSV is a common respiratory virus that usually causes
August 18, 2023
Fall is on the way! Days are getting shorter, leaves are changing colors, and school is starting. Here are a few safety tips to help enjoy this beautiful weather.
August 14, 2023
Company Logo MindMed Investor Presentation August 2023 Disclaimer This presentation has been prepared by Mind Medicine Inc. solely for informational purposes. None of... -Today at 05:35 pm- MarketScreener
August 4, 2023
More than 50 million people in the United States have an allergic reaction each year. You are more likely to have allergies and a reaction if your parents had them.
July 31, 2023
IShowSpeed, a popular American YouTuber, has been diagnosed with cluster headaches.
July 31, 2023
iShowSpeed, a well-known internet personality and streamer, recently uploaded a worrisome video where he is seen hurriedly taken to the hospital due to what he describes as a "deadly headache."
July 21, 2023
Headaches are something all of us endure at some point in time. When ignored, sometimes they turn severe and can cause migraines, nausea and even vomiting. On the eve of World Brain Day, read on to what can cause headaches and a few ways to get over them. , Health News, Times Now
June 25, 2023
Cluster headache is a periodic, intense, sharp, burning and explosive pain that begins suddenly on one side of the head and tends to get worse quickly, reaching its peak within 10 minutes.
May 26, 2023
A worldwide Headache Disorders market research report offers an array of insights about Headache Disorders industry and business solutions that will support to stay ahead of the competition. A systematic investment analysis is also underlined in this report which forecasts impending opportunities for the market play...
April 28, 2023
The oral CGRP receptor antagonist atogepant is now approved to prevent migraine across frequencies, including episodic and chronic migraine.